BiotechTube
Home/CFM Pharma/Drs. Henk J.C. Meijerink
DH

Drs. Henk J.C. Meijerink

Chief Medical Officer

CFM Pharma

Therapeutic Areas

CardiovascularDermatologyNephrology

CFM Pharma Pipeline

DrugIndicationPhase
VANADIS® BMOVMyocardial InfarctionPhase 1
VANADIS® (Burn)Severe Burns (2nd/3rd degree)Pre-clinical
VANADIS® (AKI)Acute Kidney InjuryPre-clinical

Leadership Team at CFM Pharma

DI
Drs. Ing. Lekhram Changoer
CEO
ID
Ir. David Havenaar
Legal & Finance Director
View full CFM Pharma profile